PharmD Degree Program

The Kidney Project earns KidneyX award to make home dialysis better for patients

Thu May 2, 2019

Shuvo Roy, PhD, earned an award from KidneyX that will fund the development of an easy-to-use home dialysis system for kidney disease patients.

A team led by Shuvo Roy, PhD, recently won an award that will fund the development of an easy-to-use, safe, and effective home dialysis system.

School reflects on legacy of achievement at Alumni Weekend 2019

Wed May 1, 2019

Elena Graham

Former School of Pharmacy dean Mary Anne Koda-Kimble, PharmD ’69, left, chats with current dean B. Joseph Guglielmo, PharmD, after the morning session on the new doctor of pharmacy curriculum at UCSF Alumni Weekend 2019.

Students, faculty, staff, and alumni celebrated the School of Pharmacy's long history of achievement in the discovery and clinical sciences, and clinical practice, at Alumni Weekend 2019.

Study shows promise for hormonal contraception services in the community pharmacy setting

Tue Apr 30, 2019

Susan Merrell

Lisa Kroon, PharmD

A study shows the potential of hormonal contraceptives at pharmacies in California and Oregon.

Training computers to think more like scientists

Fri Apr 19, 2019

Machine learning algorithms can be trained to distinguish wolves from dogs in photographs, but sometimes these algorithms learn incorrectly by assuming that any animal pictured with snow in the background is a wolf (bottom right). Two School scientists argue that scientific applications of machine learning also need to be monitored to ensure they are working properly.

Michael Keiser, PhD, and Kangway Chuang, PhD, want to use machine learning to speed the pace of drug discovery. By digging into the work of another lab, the pair realized how machine learning could lead scientists astray—and came up with methods to avoid its worst pitfalls.

Dong receives Daniel B. Smith Practice Excellence Award for exceptional career

Mon Apr 15, 2019

Betty J. Dong, PharmD ’72, is a world expert on HIV and hepatitis C medication therapy

Dong is a world expert on human immunodeficiency virus (HIV) and hepatitis C medication therapy

Making better pediatric chemo treatments, and delivering them to more children

Thu Apr 4, 2019

Elisabeth Fall

Janel Long-Boyle, PhD, PharmD, has spent her career making chemotherapy safe for young patients.

Janel Long-Boyle has spent her career advancing chemotherapy treatments for young patients.

Kortemme and Desai honored at annual meeting of the American Institute for Medical and Biological Engineering

Thu Mar 28, 2019

UCSF Precision Medicine

New and established AIMBE fellows (left to right): Shuvo Roy, PhD, Julius Guccione, PhD, Thomas Link, PhD, Tanja Kortemme, PhD, Atul Butte, PhD, and Tejal Desai, PhD.

School of Pharmacy faculty members Tanja Kortemme and Tejal Desai both received honors at the annual meeting of the American Institute for Medical and Biological Engineering.

Demanding change: 2019 Distinguished Alumnus Glen L. Stimmel, PharmD

Fri Mar 15, 2019

Glen L. Stimmel has had a distinguished career in pharmacy.

“Challenging the status quo leads to very good things,” said Glen L. Stimmel, PharmD ’72, who has spent a career doing just that. As a motto, it has served him, and his profession, quite well.

2019 Koda-Kimble Seed Award supports School of Pharmacy’s boldest ideas

Tue Mar 12, 2019

Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy

The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.

School of Pharmacy scientists unearth a new target for treating Parkinson’s disease

Thu Mar 7, 2019

Neuronal protein with newly-identified drug target highlighted

England Lab/UCSF

A team led by Pamela England, PhD, identified a new target (yellow) for future Parkinson’s disease therapies within the Nurr1 protein (blue).

Scientists in the UCSF School of Pharmacy recently identified the first drug-binding target site on a molecule known to play a role in Parkinson's disease, opening the door to a new generation of therapies for the condition.

PharmD Degree Program

Pages